TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15088780

Group type: EXPERIMENTAL
Intervention: Intranasal administration of laboratory passaged wild-type influenza viruses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attenuated viruses inoculation in children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum antibody
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protective factors in adults with lower levels of HI antibody
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mucosal antibody measurement
Number of subjects: 0
Study: 11938829

Group type: EXPERIMENTAL
Intervention: Modified Taohong Siwu Decoction (MTSD)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Heparin (Control)
Number of subjects: 95
Study: 9172023

Group type: EXPERIMENTAL
Intervention: Ohmeda 3740 (ear probe)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nellcor N200 reflectance oximeter
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Novametrix Oxypleth
Number of subjects: 8
Study: 1400915

Group type: EXPERIMENTAL
Intervention: Early computed tomography (CT) findings
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Late computed tomography (CT) findings
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Parenchymal lesions in the right hemisphere
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Parenchymal lesions in the left hemisphere
Number of subjects: 53
Study: 3890805

Group type: EXPERIMENTAL
Intervention: Biobrane
Number of subjects: 31

Group type: COMPARATOR
Intervention: Scarlet Red
Number of subjects: 31
Study: 30398646

Group type: EXPERIMENTAL
Intervention: Quercetin 3-glucoside (160 mg/d)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: (−)-Epicatechin (100 mg/d)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 27234606

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermocoagulation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Monopolar radiofrequency thermocoagulation (control group)
Number of subjects: 168
Study: 24388057

Group type: EXPERIMENTAL
Intervention: Biofeedback cycling training (30 minutes/time, 5 times per week for 4 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Biofeedback cycling training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 31
Study: 21732500

Group type: EXPERIMENTAL
Intervention: Family workshops with educational and skills-based components
Number of subjects: 48

Group type: COMPARATOR
Intervention: Individual family work
Number of subjects: 48
Study: 20447925

Group type: EXPERIMENTAL
Intervention: Milk consumption during adulthood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactase persistence genotype at rs4988235 among controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactase persistence genotype at rs4988235 in RCC patients
Number of subjects: 0
Study: 18949902

Group type: EXPERIMENTAL
Intervention: Combined cervical plexus block
Number of subjects: 324

Group type: COMPARATOR
Intervention: Superficial cervical plexus block
Number of subjects: 324
Study: 15763304

Group type: EXPERIMENTAL
Intervention: Henschke shielded applicator
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fletcher-Suit-Declos applicator
Number of subjects: 20
Study: 12509211

Group type: EXPERIMENTAL
Intervention: Exposure to Mozart's Sonata K.448 (Mozart effect)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Musicians
Number of subjects: 40

Group type: COMPARATOR
Intervention: Years spent in music training
Number of subjects: 40
Study: 10848143

Group type: EXPERIMENTAL
Intervention: active cognitive stimulation
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: passive stimulation
Number of subjects: 87

Group type: COMPARATOR
Intervention: control
Number of subjects: 87
Study: 8753943

Group type: EXPERIMENTAL
Intervention: Clear go signals
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ambiguous go signals
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: No-go signals
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 1834099

Group type: EXPERIMENTAL
Intervention: Sufentanil 20 micrograms added to 0.5% bupivacaine and epinephrine (1:200,000)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sufentanil 30 micrograms added to 0.5% bupivacaine and epinephrine (1:200,000)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study: 7124311

Group type: COMPARATOR
Intervention: Halothane anaesthesia
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neurolept anaesthesia
Number of subjects: 32
Study: 27377563

Group type: EXPERIMENTAL
Intervention: Stress management skills
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Fight avoidance skills
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Emotional distress
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Self-esteem
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Stress management skills and fight avoidance skills (combined)
Number of subjects: 253
Study: 28743816

Group type: EXPERIMENTAL
Intervention: Higher levels of penile anaerobes in uncircumcised men who became infected with HIV during the trial.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased abundances of anaerobic bacteria.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Penile anaerobes as a risk factor for HIV.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Penile anaerobes shared between heterosexual partners.
Number of subjects: 0
Study: 26729441

Group type: EXPERIMENTAL
Intervention: Intermediate Risk with Good Response (IR-GR) - 4 cycles of platinum and etoposide (PE)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Intermediate Risk with Partial Response (IR-PR) - 3 cycles of PE plus 3 cycles of ifosfamide, vinblastine, and bleomycin
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: High Risk with Good Response (HR-GR) - 4 cycles of PE and ifosfamide (PEI)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: High Risk with Partial Response (HR-PR) - 6 cycles of PEI
Number of subjects: 579
Study: 24433317

Group type: EXPERIMENTAL
Intervention: Continuous wound infusion of a local anaesthetic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard intravenous piritramide
Number of subjects: 60
Study: 22987676

Group type: EXPERIMENTAL
Intervention: Young adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0
Study: 19846031

Group type: EXPERIMENTAL
Intervention: Ustekinumab (45 mg and 90 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0
Study: 17536648

Group type: EXPERIMENTAL
Intervention: 10-meter timed walk (10TW)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 30-meter timed walk (30TW)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG) test
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All tests combined
Number of subjects: 43
Study: 14750091

Group type: EXPERIMENTAL
Intervention: Combination therapy with benazepril 5 mg and losartan 25 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Losartan (greater dose)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Benazepril (greater dose)
Number of subjects: 24
Study: 11581447

Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo), 400 U/kg 3 times weekly
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo/control
Number of subjects: 290
Study: 9557587

Group type: EXPERIMENTAL
Intervention: Repetitive wrist flexion at various angles (10 degrees, 28 degrees, 45 degrees) and forces (5 N, 25 N, 50 N)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous biomechanical measures processed through a force and frequency-weighted filter
Number of subjects: 10
Study: 8312419

Group type: EXPERIMENTAL
Intervention: Single-cuff Swan neck catheter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single-cuff Tenckhoff catheter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both catheters
Number of subjects: 40
Study: 3072355

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 31945308

Group type: EXPERIMENTAL
Intervention: Low sexual desire prevalence
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Sexual arousal
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Higher educational attainment
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Non-gynaecological cancer
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Pelvic inflammatory disease
Number of subjects: 25446

Group type: EXPERIMENTAL
Intervention: Pelvic pain
Number of subjects: 25446
Study: 29973259

Group type: EXPERIMENTAL
Intervention: Social and Behavioural Change Communication (SBCC) interventions for HIV and TB stigma reduction activities at three social-ecology levels (individual, community, and socio-structural)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 8
Study: 28107772

Group type: EXPERIMENTAL
Intervention: Contingent Reinforcement (CR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-Contingent Reinforcement (NR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-report (both groups)
Number of subjects: 30
Study: 26324176

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23910197

Group type: EXPERIMENTAL
Intervention: Chemically cured adhesive
Number of subjects: 220

Group type: COMPARATOR
Intervention: Light-cured adhesive
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 220
Study: 22029243

Group type: EXPERIMENTAL
Intervention: Deliberate practice sessions (6 minutes, once a month)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no practice beyond initial training)
Number of subjects: 0
Study: 17356555

Group type: EXPERIMENTAL
Intervention: Fermented milk drink containing LGG, La-5 and Bb-12, n=46
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo with heat-killed bacteria, n=41
Number of subjects: 87
Study: 16585662

Group type: EXPERIMENTAL
Intervention: Established intervention
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Established plus DASH intervention
Number of subjects: 810

Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 810
Study: 12879279

Group type: EXPERIMENTAL
Intervention: Phenylacetate (PAA) administered as a 30-min i.v. infusion at a dose of 1.8 g/m2
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Phenylacetate (PAA) administered as a 30-min i.v. infusion at a dose of 2.5 g/m2
Number of subjects: 27
Study: 11393682

Group type: EXPERIMENTAL
Intervention: Heart rate-lowering calcium antagonists (verapamil or diltiazem)
Number of subjects: 1325
Study: 9713177

Group type: EXPERIMENTAL
Intervention: Continuous force application of 50 cN for 4 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous force application of 100 cN for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non‐moved control teeth
Number of subjects: 12
Study: 7999485

Group type: EXPERIMENTAL
Intervention: Sufentanil 33.2 micrograms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Alfentanil 654 micrograms
Number of subjects: 14
Study: 3294122

Group type: EXPERIMENTAL
Intervention: Erythromycin or spiramycin
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Antidiarrhoeal agents (long acting morphine sulphate)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 26
Study: 31335356

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 65
Study: 27144498

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy combined with conventional gel
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional gel only (Control)
Number of subjects: 22
Study: 25891453

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) combination group
Number of subjects: 128

Group type: COMPARATOR
Intervention: Western medicine control group
Number of subjects: 128
Study: 23370584

Group type: EXPERIMENTAL
Intervention: Postural drainage (PD)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (Con)
Number of subjects: 47
Study: 22411386

Group type: EXPERIMENTAL
Intervention: Paper and pencil FFQ
Number of subjects: 50

Group type: COMPARATOR
Intervention: Online FFQ
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both presentations
Number of subjects: 50
Study: 19335912

Group type: EXPERIMENTAL
Intervention: Intramucosal pH (pHi) >or= 7.32
Number of subjects: 130

Group type: COMPARATOR
Intervention: Cardiac index (CI) >or= 3.0 L/min/m2
Number of subjects: 130
Study: 16688978

Group type: EXPERIMENTAL
Intervention: Personal letter from consultant summarising consultation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Brief note thanking for attending clinic
Number of subjects: 150
Study: 15488400

Group type: EXPERIMENTAL
Intervention: High-demand subtraction task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-demand subtraction task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-demand subtraction task with novel distractors
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-demand subtraction task with novel distractors
Number of subjects: 0
Study: 11775649

Group type: EXPERIMENTAL
Intervention: Essaven gel (EG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9279488

Group type: EXPERIMENTAL
Intervention: Active dynamic technique (leg extension)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Passive dynamic technique (knee oscillation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Static techniques (massage and isometric quadriceps contractions)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 8290660

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30717951

Group type: EXPERIMENTAL
Intervention: Stent grafts
Number of subjects: 269

Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 269
Study: 27465622

Group type: EXPERIMENTAL
Intervention: Recent stressful life events (SLEs)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Stress-related symptoms (SRSs)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Total HRQoL
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Mean values of HRQoL
Number of subjects: 351
Study: 26333655

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin T (hs-cTnT) measurement
Number of subjects: 1074

Group type: COMPARATOR
Intervention: Serelaxin treatment
Number of subjects: 1074
Study: 25489512

Group type: EXPERIMENTAL
Intervention: Spreader graft
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overlapping lateral crural technique
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study: 20938444

Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg Kg(‐1) infusion for 1 hour)
Number of subjects: 30
Study: 18708300

Group type: EXPERIMENTAL
Intervention: Oxycodone PR/naloxone PR
Number of subjects: 463

Group type: COMPARATOR
Intervention: Oxycodone PR
Number of subjects: 463
Study: 16621667

Group type: EXPERIMENTAL
Intervention: 'Slouched' posture for 300 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 'Slouched' posture for 5 minutes
Number of subjects: 32
Study: 12794203

Group type: EXPERIMENTAL
Intervention: On-site syphilis testing conducted by primary care nurses
Number of subjects: 7134

Group type: COMPARATOR
Intervention: Laboratory testing alone
Number of subjects: 7134

Group type: EXPERIMENTAL
Intervention: On-site syphilis testing
Number of subjects: 7134
Study: 11082353

Group type: EXPERIMENTAL
Intervention: ATS mechanical aortic valve
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Carbomedics mechanical aortic valve
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: St Jude Medical Hemodynamic Plus mechanical aortic valve
Number of subjects: 300
Study: 8922355

Group type: EXPERIMENTAL
Intervention: Dietary intervention (avoidance of cow's milk proteins)
Number of subjects: 20
Study: 1735849

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal) 5 ml/kg
Number of subjects: 215
Study: 6239561

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcuronium
Number of subjects: 0
Study: 30887760

Group type: EXPERIMENTAL
Intervention: Limited-excision
Number of subjects: 100

Group type: COMPARATOR
Intervention: LLETZ
Number of subjects: 100
Study: 30534816

Group type: EXPERIMENTAL
Intervention: En bloc bipolar ablation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional TURBT
Number of subjects: 90
Study: 27091562

Group type: EXPERIMENTAL
Intervention: Child-reported break-time foods
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Child-reported sugar-sweetened beverages (SSB) consumption
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Parent-reported and child-reported water and fruit consumption
Number of subjects: 407
Study: 25198235

Group type: EXPERIMENTAL
Intervention: Deadlift training (twice per week)
Number of subjects: 54
Study: 22267245

Group type: EXPERIMENTAL
Intervention: sodium bicarbonate (166 mEq/L) 3 mL/kg for 1 h before and 1 mL/kg/h for 6 h after the procedure (Group B)
Number of subjects: 258

Group type: COMPARATOR
Intervention: sodium chloride 0.9% 1 mL/kg/h for at least 12h prior and after the procedure (Group A)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: sodium bicarbonate (166 mEq/L) 3 mL/kg over 20 min before the procedure plus sodium bicarbonate orally (500 mg per 10 kg) (Group C)
Number of subjects: 258
Study: 20716988

Group type: EXPERIMENTAL
Intervention: Auditory feedback signal (Sensor group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: External device used to restrain the trunk (Stabilizer group)
Number of subjects: 16
Study: 17192294

Group type: EXPERIMENTAL
Intervention: rhIGF‐I administered sc in doses between 60 and 120 microg/kg twice daily
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: rhIGF‐I
Number of subjects: 76
Study: 14712431

Group type: COMPARATOR
Intervention: 4 hours dialysis 3 times weekly
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 5 hours dialysis 3 times weekly
Number of subjects: 21

Group type: COMPARATOR
Intervention: No exercise
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise predialysis
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise during dialysis
Number of subjects: 21
Study: 12352419

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open prostatectomy
Number of subjects: 120
Study: 9887898

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Antibiotics (Western medicine)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian
Number of subjects: 27
Study: 7986302

Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin once daily for 6 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin twice daily for 6 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 20 mg of fluvastatin (both dosages)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 2554766

Group type: EXPERIMENTAL
Intervention: LY171883 (600 mg) twice daily for 6 weeks
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 31005345

Group type: EXPERIMENTAL
Intervention: Electronic Hand Hygiene Monitoring System (EHHMS)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Human observation (pre-implementation)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Human observation (post-implementation)
Number of subjects: 91
Study: 28371685

Group type: EXPERIMENTAL
Intervention: Low-intensity cathodal direct current (CDC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study: 25358059

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSEA)
Number of subjects: 65

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 65
Study: 23635604

Group type: EXPERIMENTAL
Intervention: Spironolactone (25 mg) administered 1 day before and 3 days posttransplantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21902995

Group type: EXPERIMENTAL
Intervention: NuSmile(®) crown
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Kinder™Krown
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Parental satisfaction
Number of subjects: 18

Group type: COMPARATOR
Intervention: Crown wear
Number of subjects: 18
Study: 19837425

Group type: EXPERIMENTAL
Intervention: Polyvinyl chloride catheter
Number of subjects: 195

Group type: COMPARATOR
Intervention: Polyvinyl chloride-free catheter
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study: 16393591

Group type: EXPERIMENTAL
Intervention: L.M.X.4 cream (4% liposomal lidocaine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: EMLA cream (2.5% lidocaine and 2.5% prilocaine)
Number of subjects: 40
Study: 14552846

Group type: EXPERIMENTAL
Intervention: IDEATel intervention, a home-based telemedicine system
Number of subjects: 25
Study: 10768435

Group type: EXPERIMENTAL
Intervention: 1200 mg of anti-digoxin Fab
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 66
Study: 8829177

Group type: EXPERIMENTAL
Intervention: Ethanol (0.07 +/- 0.003 g/dl)
Number of subjects: 12
Study: 1425887

Group type: EXPERIMENTAL
Intervention: Mianserin (60 mg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Imipramine (dose adjusted for optimal plasma concentration of 400-600 nmol.l-1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18